Jeremy VisserJul 13, 20231 min readLong Term Efficacy of DeucravacitinibDr. Ronald B. Vender discusses the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.
Dr. Ronald B. Vender discusses the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.
Comments